| Authors: |
Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia., Maher NG; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Mesbah Ardakani N; Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Australia., Jackett LA; Peter MacCallum Cancer Centre, Melbourne, Australia., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia., Gonzalez M; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Burton EM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Lucas MW; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Reijers ILM; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rozeman EA; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Westmead Hospital, Sydney, Australia; Blacktown Hospital, Sydney, Australia., Howle J; Westmead Hospital, Sydney, Australia., Khattak M; Fiona Stanley Hospital, Edith Cowan University, Perth, Australia., Van der Westhuizen A; Lake Macquarie Oncology, Lake Macquarie Private Hospital, The Department of Medicine, University of Newcastle, Newcastle, Australia., Andrews MC; Department of Medical Oncology, Alfred Health, Melbourne, Australia; Department of Medicine, School of Translational Medicine, Monash University, Melbourne, Australia., Atkinson V; Princess Alexandra Hospital, University of Queensland, Brisbane, Australia., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia., van de Wiel BA; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blank CU; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Tetzlaff MT; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California, San Francisco, USA. Electronic address: michael.tetzlaff@ucsf.edu., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: Richard.Scolyer@health.nsw.gov.au. |
